Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

Blood. 2007 Jan 1;109(1):228-34. doi: 10.1182/blood-2006-02-002246. Epub 2006 Sep 19.

Abstract

The molecular mechanisms by which mesenchymal stem cells (MSCs) suppress T-cell proliferation are poorly understood, and whether a soluble factor plays a major role remains controversial. Here we demonstrate that the T-cell-receptor complex is not a target for the suppression, suggesting that downstream signals mediate the suppression. We found that Stat5 phosphorylation in T cells is suppressed in the presence of MSCs and that nitric oxide (NO) is involved in the suppression of Stat5 phosphorylation and T-cell proliferation. The induction of inducible NO synthase (NOS) was readily detected in MSCs but not T cells, and a specific inhibitor of NOS reversed the suppression of Stat5 phosphorylation and T-cell proliferation. This production of NO in the presence of MSCs was mediated by CD4 or CD8 T cells but not by CD19 B cells. Furthermore, inhibitors of prostaglandin synthase or NOS restored the proliferation of T cells, whereas an inhibitor of indoleamine 2,3-dioxygenase and a transforming growth factor-beta-neutralizing antibody had no effect. Finally, MSCs from inducible NOS-/- mice had a reduced ability to suppress T-cell proliferation. Taken together, these results suggest that NO produced by MSCs is one of the major mediators of T-cell suppression by MSCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD19 / analysis
  • B-Lymphocyte Subsets / cytology
  • B-Lymphocyte Subsets / drug effects
  • B-Lymphocyte Subsets / metabolism
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / cytology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Division / drug effects
  • Cell Line
  • Concanavalin A / pharmacology
  • Cyclooxygenase Inhibitors / pharmacology
  • Dinoprostone / physiology
  • Enzyme Induction / drug effects
  • HeLa Cells
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / antagonists & inhibitors
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / physiology
  • Interferon-gamma / biosynthesis
  • Interleukin-2 / biosynthesis
  • Ionomycin / pharmacology
  • Lymphocyte Activation / drug effects
  • Macrophages / physiology
  • Mesenchymal Stem Cells / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / biosynthesis
  • Nitric Oxide / pharmacology
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / deficiency
  • Nitric Oxide Synthase Type II / metabolism
  • Phosphorylation / drug effects
  • Prostaglandin-Endoperoxide Synthases / physiology
  • Protein Processing, Post-Translational / drug effects
  • Receptors, Antigen, T-Cell / physiology
  • STAT5 Transcription Factor / metabolism
  • Signal Transduction
  • T-Lymphocyte Subsets / cytology
  • T-Lymphocyte Subsets / drug effects*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transforming Growth Factor beta / antagonists & inhibitors
  • Transforming Growth Factor beta / immunology
  • Tryptophan / analogs & derivatives
  • Tryptophan / pharmacology

Substances

  • Antigens, CD19
  • Cyclooxygenase Inhibitors
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Interleukin-2
  • Receptors, Antigen, T-Cell
  • STAT5 Transcription Factor
  • Transforming Growth Factor beta
  • Concanavalin A
  • Nitric Oxide
  • Ionomycin
  • Interferon-gamma
  • Tryptophan
  • Nitric Oxide Synthase Type II
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone
  • Tetradecanoylphorbol Acetate
  • NG-Nitroarginine Methyl Ester